Overview

Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis

Status:
Suspended
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness of DermiPsor's DPS-102 (test product) in patients with scalp Psoroasis. The study is also intended to assess the safety of the product.
Phase:
Phase 2
Details
Lead Sponsor:
DermiPsor, Ltd.
Treatments:
Calcipotriene
Niacin
Niacinamide
Nicotinic Acids